272 related articles for article (PubMed ID: 18575195)
21. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():25-36. PubMed ID: 18575189
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.
Bussmann H; de la Hoz Gomez F; Roels TH; Wester CW; Bodika SM; Moyo S; Taffa N; Anderson MG; Mine M; Bile EC; Yang C; Mphoyakgosi K; Lehotzky EA; Mlotshwa B; Mmelesi M; Seipone K; Makhema MJ; Marlink RG; Novitsky V; Essex M
AIDS Res Hum Retroviruses; 2011 Apr; 27(4):365-72. PubMed ID: 21034246
[TBL] [Abstract][Full Text] [Related]
24. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
25. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
[TBL] [Abstract][Full Text] [Related]
26. [The introduction of antiretroviral therapy in Malawi].
Zijlstra EE; van Oosterhout JJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
[TBL] [Abstract][Full Text] [Related]
27. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
Bennett DE
Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
[TBL] [Abstract][Full Text] [Related]
28. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
[TBL] [Abstract][Full Text] [Related]
29. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings.
Cambiano V; Bertagnolio S; Jordan MR; Lundgren JD; Phillips A
J Infect Dis; 2013 Jun; 207 Suppl 2():S57-62. PubMed ID: 23687290
[TBL] [Abstract][Full Text] [Related]
30. Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.
Dilernia DA; Lourtau L; Gomez AM; Ebenrstejin J; Toibaro JJ; Bautista CT; Marone R; Carobene M; Pampuro S; Gomez-Carrillo M; Losso MH; Salomón H
AIDS; 2007 Jun; 21(10):1355-60. PubMed ID: 17545713
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
Wadonda-Kabondo N; Bennett D; van Oosterhout JJ; Moyo K; Hosseinipour M; Devos J; Zhou Z; Aberle-Grasse J; Warne TR; Mtika C; Chilima B; Banda R; Pasulani O; Porter C; Phiri S; Jahn A; Kamwendo D; Jordan MR; Kabuluzi S; Chimbwandira F; Kagoli M; Matatiyo B; Demby A; Yang C
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S362-8. PubMed ID: 22544204
[TBL] [Abstract][Full Text] [Related]
32. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi.
Moses A; Zimba C; Kamanga E; Nkhoma J; Maida A; Martinson F; Mofolo I; Joaki G; Muita J; Spensley A; Hoffman I; van der Horst CM;
AIDS; 2008 Jan; 22(1):83-7. PubMed ID: 18090395
[TBL] [Abstract][Full Text] [Related]
33. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
Wadonda-Kabondo N; Hedt BL; van Oosterhout JJ; Moyo K; Limbambala E; Bello G; Chilima B; Schouten E; Harries A; Massaquoi M; Porter C; Weigel R; Hosseinipour M; Aberle-Grasse J; Jordan MR; Kabuluzi S; Bennett DE
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S355-61. PubMed ID: 22544203
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
36. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
Muula AS
Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
[TBL] [Abstract][Full Text] [Related]
37. Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
Ma Y; Zhang F; Li H; Wu H; Zhang J; Ding Y; Zhao D; Fang H; Zhou S; Liu Z; Zhang L; Osborne C; Seguy N; Zhao Y
Clin Infect Dis; 2012 May; 54 Suppl 4():S300-2. PubMed ID: 22544191
[TBL] [Abstract][Full Text] [Related]
38. Low level of transmitted HIV Drug resistance at two HIV care centres in Ghana: a threshold survey.
Bonney EY; Addo NA; Ntim NA; Addo-Yobo F; Bondzie P; Aryee KE; Barnor J; Brandful J; Bekoe V; Ohene SA; Ampofo W
Ghana Med J; 2013 Jun; 47(2):82-6. PubMed ID: 23966745
[TBL] [Abstract][Full Text] [Related]
39. [Study on the drug resistance situation among recently infected HIV-1 patients in Dehong].
Wang MJ; Duan S; Xiang LF; Yang YC; Tu YQ; Wang JB; Yao J; Qi J; Jiang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):905-8. PubMed ID: 19173856
[TBL] [Abstract][Full Text] [Related]
40. [Drug resistance in HIV infection].
Asjö B; Langeland N
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2593-6. PubMed ID: 19023373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
